AI-Designed Vaccine Promises Universal Protection Against Viruses Including Covid-19 and Ebola
Researchers have developed a revolutionary new method to prevent people from falling ill from viruses with pandemic potential, even before they become a real threat. The technology, dubbed a universal vaccine, was developed by a team led by the University of Cambridge.
The team believes the technology can be used to create a single injection offering broad protection against thousands of virus variants, such as the coronavirus group or Ebola. For the first time in history, the team harnessed artificial intelligence (AI) to design a super-antigen that provides long-lasting protection against various types of viruses, even as they continue to mutate.
The key difference of this technology lies in its effectiveness compared to traditional vaccines. Currently, flu and Covid-19 vaccines use antigens from specific strains or variants of the virus detected in humans. This leaves the medical world in a constant race against evolving mutations.
“We are changing vaccine development from being reactive to being future-proof,” said Professor Jonathan Heeney, the research lead from the Lab of Viral Zoonotics, Department of Veterinary Medicine at the University of Cambridge.
According to Heeney, the new vaccine overcomes the limitations of traditional vaccines whose protection is restricted. “This means we can break out of the constant cycle of chasing circulating viral variants in humans, like a dog chasing its own tail,” he added.
The results of the first human trials, published in the Journal of Infection, show promising outcomes. The vaccine was declared safe, well-tolerated, and caused only minimal side effects. A total of 39 volunteers aged 18 to 50 were given the universal coronavirus vaccine, Sarbeco.
The vaccine covers a large group of viruses existing in nature, including SARS-CoV-2. Researchers noted that the vaccine triggered an immune response not only against SARS-CoV-2 and SARS, but also against related bat viruses that could potentially jump to humans in the future.
This technology also brings hope amid global concerns over the Ebola outbreak in Uganda and the Democratic Republic of Congo, which has caused thousands of illnesses and hundreds of deaths. Currently, there is no officially approved vaccine for certain strains, such as the Bundibugyo strain, which has a fatality rate of 30 to 50 per cent.
Professor Saul Faust from the University of Southampton stressed the importance of this clinical advancement for a new class of vaccines. “If we can develop these vaccines before an outbreak begins, millions of lives could be saved, lockdowns could be avoided, and economic stability could be maintained,” he concluded.
Source: jawawa.id (https://jawawa.id/newsitem/ai-designed-vaccine-promises-universal-protection-against-viruses-including-covid-19-and-ebola-1781322638)
Originally published by Media Indonesia (https://mediaindonesia.com/humaniora/900085/vaksin-ai-dijamin-ampuh-tangkal-semua-virus-termasuk-covid-19-dan-ebola), translated from Indonesian